Treatment status, survival and gene expression analysis of large-cell neuroendocrine lung carcinoma: a real-world study in China
LCNEC is a highly aggressive disease and incorporation of immunotherapy might be an effective treatment option.
Authors
- Minghang Zhang
- Hongmei Zhang (ORCID: https://orcid.org/0000-0002-2866-8227)
- Yi Han (ORCID: https://orcid.org/0009-0004-0687-4945)
- Ligang Zhang (ORCID: https://orcid.org/0000-0002-7520-6084)
- Juan Du (ORCID: https://orcid.org/0000-0002-5068-3992)
- Tongmei Zhang (ORCID: https://orcid.org/0000-0003-4271-3773)
- Fei Qi (ORCID: https://orcid.org/0000-0002-4853-2845)
- Hongjie Yang
Institutions
- Capital Medical University (CN)
- Beijing Chest Hospital (CN)
- Affiliated Hospital of Shaanxi University of Chinese Medicine (CN)
Publication Details
- Journal
- Therapeutic Advances in Medical Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17588359251324900
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00